Kee Song Bio-Technology Holdings (ROCO:1258) ROCE % : 19.18% (As of Mar. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kee Song Bio-Technology Holdings's annualized ROCE % for the quarter that ended in Mar. 2023 was 19.18%.

Kee Song Bio-Technology Holdings ROCE % Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings ROCE % Chart

Kee Song Bio-Technology Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-6.58

-5.49

2.16

7.90

11.03

Kee Song Bio-Technology Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
ROCE %	Get a 7-Day Free Trial															9.40	18.41	-10.69	27.18	19.18

Kee Song Bio-Technology Holdings ROCE % Calculation

Kee Song Bio-Technology Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	176.794	/	( ( (2141.568 - 620.641)	+	(2341.95 - 657.031) )	/ 2 )
	=	176.794	/	( (1520.927	+	1684.919)	/ 2 )
	=	176.794	/	1602.923
	=	11.03 %

Kee Song Bio-Technology Holdings's ROCE % of for the quarter that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2023 )		(Q: Dec. 2022 )		(Q: Mar. 2023 )
	=	324.192	/	( ( (2341.95 - 657.031)	+	(2266.869 - 571.27) )	/ 2 )
	=	324.192	/	( ( 1684.919	+	1695.599 )	/ 2 )
	=	324.192	/	1690.259
	=	19.18 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2023) EBIT data.

Kee Song Bio-Technology Holdings (ROCO:1258) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kee Song Bio-Technology Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104

Website

https://www.keesongbiotech.com

Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines